Cardiac Insight Touts New $4.5 Million Investment

Cardiac Insight, Inc., a U.S. developer of wearable medical devices and diagnostic software, confirmed to MHW today that the company continues to experience a steady beat of market traction and industry endorsement with a recent infusion of $4.5 million into their new C-1 round of funding, currently capped at $10 million, and the addition of experienced healthcare executives to its board and leadership team.

According to a shared media release, the company also unveiled the formation of an exclusive Scientific Advisory Board, to be chaired by top cardiologist and former Heart Rhythm Society president, Dr. Robert Hauser.

“Cardiac Insight has quickly caught the attention of the cardiology community for our game-changing products and revolutionary approach to cardiac care,” said Brad Harlow, Co-Founder and Chief Executive Officer at Cardiac Insight, Inc. “Our new funding and leadership additions will continue to propel the company forward and highlight our distinct value proposition to cardiologists, healthcare institutions and patients.”

Harlow added that the new investment would be used to support its Cardea SOLO 7-day ECG sensor production, sales, distribution and marketing to the cardiac communities.

To learn more about Cardiac Insight, click here.

This post was written by:

- who has written 2293 posts on mHealthWatch.

Contact the author